The Importance of Therapeutic Drug Monitoring in Hidradenitis Suppurativa

被引：0
|
作者：
Ciudad Blanco, Cristina [1 ]
Rosell Diaz, Angel [1 ]
Nieto Benito, Lula Maria [1 ]
Suarez Fernandez, Ricardo [1 ]
机构：
[1] Hosp Gregorio Maranon, Dermatol, Madrid, Spain
来源：
EXPERIMENTAL DERMATOLOGY | 2021年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P16
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [1] Therapeutic drug level monitoring in patient with hidradenitis suppurativa
    Alter, Mareike
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 89 - 89
  • [2] Evaluation of barriers to therapeutic drug monitoring in the management of hidradenitis suppurativa
    Hilerowicz, Y.
    Levin, N. J.
    Parmar, J.
    Halavi, A.
    Lev-Tov, H.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) : 936 - 938
  • [3] Evaluation of barriers to therapeutic drug monitoring in the management of hidradenitis suppurativa
    Hilerowicz, Yuval
    Levin, Nicole
    Palmar, Jayesh
    Halavi, Afsaneh
    Lev-Tov, Hadar
    EXPERIMENTAL DERMATOLOGY, 2021, 30 : 67 - 67
  • [4] Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series
    Tasnim Abdalla
    Mark Mansour
    Dorra Bouazzi
    Michelle A. Lowes
    Gregor B. E. Jemec
    Afsaneh Alavi
    American Journal of Clinical Dermatology, 2021, 22 : 275 - 283
  • [5] Therapeutic Drug Monitoring in Patients with Suboptimal Response to Adalimumab for Hidradenitis Suppurativa: A Retrospective Case Series
    Abdalla, Tasnim
    Mansour, Mark
    Bouazzi, Dorra
    Lowes, Michelle A.
    Jemec, Gregor B. E.
    Alavi, Afsaneh
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (02) : 275 - 283
  • [6] Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?
    Tasnim Abdalla
    Michelle A. Lowes
    Nirmal Kaur
    Robert G. Micheletti
    A. Hillary Steinhart
    Afsaneh Alavi
    American Journal of Clinical Dermatology, 2021, 22 : 139 - 147
  • [7] Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?
    Abdalla, Tasnim
    Lowes, Michelle A.
    Kaur, Nirmal
    Micheletti, Robert G.
    Steinhart, A. Hillary
    Alavi, Afsaneh
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2021, 22 (02) : 139 - 147
  • [8] Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”
    Mafalda Pestana
    Margarida Brito Caldeira
    Joana Cabete
    American Journal of Clinical Dermatology, 2022, 23 : 591 - 592
  • [9] Comment on: "Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?"
    Pestana, Mafalda
    Brito Caldeira, Margarida
    Cabete, Joana
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2022, 23 (04) : 591 - 592
  • [10] Prolonged drug survival of adalimumab in hidradenitis suppurativa: The importance of early intervention
    Konstantinou, Maria Polina
    Krasagakis, Konstantinos
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025, 39 (01) : 29 - 30
12345